> Sirion Therapeutics has completed a merger with Sytera, a La Jolla, CA-based biopharmaceutical firm working on new treatments for dry AMD. Release > BioMS has won the approval of its data monitoring ...
Sirion Therapeutics, Inc., an ophthalmic-focused biopharmaceutical company, has completed a merger with Sytera, Inc., a biopharmaceutical firm based in La Jolla, California committed to discovering ...
KRAS-mutated tumors were once untreatable. In fact, KRAS was something of a poster child for so-called undruggability. Several laboratories are investigating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results